Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07871045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Resection in Robotic Pancreaticoduodenectomy for Pancreatic Cancer

Study acronym: VR in RPD
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Data for this propensity score-matched (PSM) comparative study were obtained from a prospectively maintained database comprising 679 cases of robotic pancreaticoduodenectomy (RPD). This study aimed to evaluate the feasibility and justification of vascular resection (VR) in RPD for pancreatic cancer. The primary study endpoint was to compare the surgical outcomes between patients undergoing VR (+) and VR (-) in RPD using PSM to minimize selection bias and allow for balanced comparisons. The secondary study endpoint was to assess the impact of VR on oncological outcomes and overall survival in patients with pancreatic cancer undergoing RPD.
Trial Details
NCT Number NCT07871045
Lead Sponsor Taipei Veterans General Hospital, Taiwan
Conditions
(from sponsor)		 Vascular Resection, Pancreatic Cancer, Robotic Pancreaticoduodenectomy
Related terms Pancreatic Neoplasms
Enrollment 239 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov